Cargando…

Protein kinase A inhibition facilitates the antitumor activity of xanthohumol, a valosin‐containing protein inhibitor

Xanthohumol (XN), a simple prenylated chalcone, can be isolated from hops and has the potential to be a cancer chemopreventive agent against several human tumor cell lines. We previously identified valosin‐containing protein (VCP) as a target of XN; VCP can also play crucial roles in cancer progress...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shikata, Yuki, Yoshimaru, Tetsuro, Komatsu, Masato, Katoh, Hiroto, Sato, Reiko, Kanagaki, Shuhei, Okazaki, Yasumasa, Toyokuni, Shinya, Tashiro, Etsu, Ishikawa, Shumpei, Katagiri, Toyomasa, Imoto, Masaya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406609/ https://www.ncbi.nlm.nih.gov/pubmed/28122154 http://dx.doi.org/10.1111/cas.13175

Ejemplares similares

Xanthohumol suppresses oestrogen-signalling in breast cancer through the inhibition of BIG3-PHB2 interactions
por: Yoshimaru, Tetsuro, et al.
Publicado: (2014)

Stapled BIG3 helical peptide ERAP potentiates anti-tumour activity for breast cancer therapeutics
por: Yoshimaru, Tetsuro, et al.
Publicado: (2017)

A-kinase anchoring protein BIG3 coordinates oestrogen signalling in breast cancer cells
por: Yoshimaru, Tetsuro, et al.
Publicado: (2017)

Functional genomics for breast cancer drug target discovery
por: Yoshimaru, Tetsuro, et al.
Publicado: (2021)

Therapeutic advances in BIG3-PHB2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancer
por: Yoshimaru, Tetsuro, et al.
Publicado: (2015)

Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (BIG3) is predicted to interact with its partner through an ARM-type α-helical structure
por: Chen, Yi-An, et al.
Publicado: (2014)

BIG3 Inhibits the Estrogen-Dependent Nuclear Translocation of PHB2 via Multiple Karyopherin-Alpha Proteins in Breast Cancer Cells
por: Kim, Nam-Hee, et al.
Publicado: (2015)

The survival and proliferation of osteosarcoma cells are dependent on the mitochondrial BIG3‐PHB2 complex formation
por: Toki, Shunichi, et al.
Publicado: (2021)

Early Growth Response 4 Is Involved in Cell Proliferation of Small Cell Lung Cancer through Transcriptional Activation of Its Downstream Genes
por: Matsuo, Taisuke, et al.
Publicado: (2014)

A chemical genomic study identifying diversity in cell migration signaling in cancer cells
por: Magi, Shigeyuki, et al.
Publicado: (2012)

SMK-17, a MEK1/2-specific inhibitor, selectively induces apoptosis in β-catenin-mutated tumors
por: Kiga, Masaki, et al.
Publicado: (2015)

Valosin Containing Protein (VCP): A Multistep Regulator of Autophagy
por: Ferrari, Veronica, et al.
Publicado: (2022)

Synthesis of xanthohumol and xanthohumol-d(3) from naringenin
por: Andrusiak, Joanna, et al.
Publicado: (2021)

Chemical Genomic-Based Pathway Analyses for Epidermal Growth Factor-Mediated Signaling in Migrating Cancer Cells
por: Magi, Shigeyuki, et al.
Publicado: (2014)

Caspase‐3 Activation Is Not Responsible for Vinblastine‐induced Bcl‐2 Phosphorylation and G2/M Arrest in Human Small Cell Lung Carcinoma Ms‐1 Cells
por: Tashiro, Etsu, et al.
Publicado: (1998)

Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease
por: Ju, Jeong-Sun, et al.
Publicado: (2009)

Valosin-Containing Protein Gene Mutations: Cellular Phenotypes Relevant to Neurodegeneration
por: Poksay, Karen S., et al.
Publicado: (2011)

Heterozygous mutations in valosin-containing protein (VCP) and resistance to VCP inhibitors
por: Bastola, Prabhakar, et al.
Publicado: (2019)

Targeting BIG3–PHB2 interaction to overcome tamoxifen resistance in breast cancer cells
por: Yoshimaru, Tetsuro, et al.
Publicado: (2013)

Involvement of Peripheral and Central Nervous Systems in a Valosin-Containing Protein Mutation
por: Segers, Kurt, et al.
Publicado: (2014)

Lysine Methylation of the Valosin-Containing Protein (VCP) Is Dispensable for Development and Survival of Mice
por: Fusser, Markus, et al.
Publicado: (2015)

Novel genomic targets of valosin-containing protein in protecting pathological cardiac hypertrophy
por: Zhou, Ning, et al.
Publicado: (2020)

Clinical Classification of Variants in the Valosin-Containing Protein Gene Associated With Multisystem Proteinopathy
por: Schiava, Marianela, et al.
Publicado: (2023)

Apoptosis induction associated with the ER stress response through up-regulation of JNK in HeLa cells by gambogic acid
por: Krajarng, Aungkana, et al.
Publicado: (2015)

Inhibition of Cyclin D1 Expression and Induction of Apoptosis by Inostamycin in Small Cell Lung Carcinoma Cells
por: Imoto, Masaya, et al.
Publicado: (1998)

Potentiation of Paclitaxel Cytotoxicity by Inostamycin in Human Small Cell Lung Carcinoma, Ms‐1 Cells
por: Simizu, Siro, et al.
Publicado: (1998)

Valosin-Containing Protein (VCP/p97) Is an Activator of Wild-Type Ataxin-3
por: Laço, Mário N., et al.
Publicado: (2012)

Valosin-containing protein regulates the proteasome-mediated degradation of DNA-PKcs in glioma cells
por: Jiang, N, et al.
Publicado: (2013)

The valosin‐containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload
por: Zhou, Ning, et al.
Publicado: (2017)

Retinoid receptor turnover mediated by sumoylation, ubiquitination and the valosin-containing protein is disrupted in glioblastoma
por: Rodriguez, Virginia, et al.
Publicado: (2019)

The Biogenesis of Dengue Virus Replication Organelles Requires the ATPase Activity of Valosin-Containing Protein
por: Mazeaud, Clément, et al.
Publicado: (2021)

Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy
por: Korb, Manisha, et al.
Publicado: (2022)

Valosin containing protein (VCP): initiator, modifier, and potential drug target for neurodegenerative diseases
por: Chu, Siwei, et al.
Publicado: (2023)

Identification of Licopyranocoumarin and Glycyrurol from Herbal Medicines as Neuroprotective Compounds for Parkinson's Disease
por: Fujimaki, Takahiro, et al.
Publicado: (2014)

Valosin-Containing Protein/p97 as a Novel Therapeutic Target in Acute Lymphoblastic Leukemia
por: Gugliotta, Gabriele, et al.
Publicado: (2017)

The valosin-containing protein is a novel mediator of mitochondrial respiration and cell survival in the heart in vivo
por: Lizano, Paulo, et al.
Publicado: (2017)

Targeting valosin‐containing protein enhances the efficacy of radiation therapy in esophageal squamous cell carcinoma
por: Luo, Hui, et al.
Publicado: (2019)

Valosin-Containing Protein (VCP)/p97: A Prognostic Biomarker and Therapeutic Target in Cancer †
por: Costantini, Susan, et al.
Publicado: (2021)

Comparative Oncology Assessment of a Novel Inhibitor of Valosin-Containing Protein in Tumor-Bearing Dogs
por: LeBlanc, Amy K., et al.
Publicado: (2022)

Involvement of endothelins in neuroprotection of valosin-containing protein modulators against retinal ganglion cell damage
por: Kusaka, Mami, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eo5erdl928brogir3kispon0th